B7-H3: An Attractive Target for Antibody-based Immunotherapy.

Kontos, Filippos; Michelakos, Theodoros; Kurokawa, Tomohiro; Sadagopan, Ananthan; Schwab, Joseph H; Ferrone, Cristina R; Ferrone, Soldano

Kontos, Filippos; Michelakos, Theodoros; Kurokawa, Tomohiro; Sadagopan, Ananthan; Schwab, Joseph H; Ferrone, Cristina R; Ferrone, Soldano.

Afiliação

Kontos F; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Michelakos T; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Kurokawa T; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Sadagopan A; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Schwab JH; Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Ferrone CR; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Ferrone S; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. sferrone@partners.org.

Clin Cancer Res ; 27(5): 1227-1235, 2021 03 01.

Article em En | MEDLINE | ID: mdl-33051306

Assuntos

Anticorpos Monoclonais/uso terapêutico; Antígenos B7/antagonistas & inibidores; Imunoterapia/métodos; Neoplasias/tratamento farmacológico; Humanos; Terapia de Alvo Molecular; Neoplasias/imunologia; Neoplasias/metabolismo; Neoplasias/patologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos B7 / Imunoterapia / Anticorpos Monoclonais / Neoplasias Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google